Neuartiger oraler Faktor Xa-Hemmer BAY 59-7939: Positive Ergebnisse der Phase II-Studie zur einmal täglichen Gabe
Year
2005
Magazine/Publisher
47. Jahrestagung der American Society of Hematology, 2005.
Keyword
Saliva, Factor Xa-Inhibitor
L/A
L
Comment
We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. See our
Privacy Policy & Cookiesyes, i accept